Müge Çevik

13.4k total citations · 2 hit papers
65 papers, 3.5k citations indexed

About

Müge Çevik is a scholar working on Infectious Diseases, Oncology and Modeling and Simulation. According to data from OpenAlex, Müge Çevik has authored 65 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 12 papers in Oncology and 11 papers in Modeling and Simulation. Recurrent topics in Müge Çevik's work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (11 papers) and COVID-19 and healthcare impacts (11 papers). Müge Çevik is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (11 papers) and COVID-19 and healthcare impacts (11 papers). Müge Çevik collaborates with scholars based in United Kingdom, United States and Switzerland. Müge Çevik's co-authors include Antonia Ho, Alberto Enrico Maraolo, Ollie Lloyd, Jenna Schafers, Matthew Tate, Jason Kindrachuk, Krutika Kuppalli, Malik Peiris, Marc Lipsitch and Connor Bamford and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Müge Çevik

63 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

2020 842 citations Müge Çevik, Matthew Tate et al. The Lancet Microbe profile →
Virology, transmission, and pathogenesis of SARS-CoV-2

2020 462 citations Müge Çevik, Krutika Kuppalli et al. profile →

Peers

Countries citing papers authored by Müge Çevik

Since Specialization

Citations

This map shows the geographic impact of Müge Çevik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Müge Çevik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Müge Çevik more than expected).

Fields of papers citing papers by Müge Çevik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Müge Çevik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Müge Çevik. The network helps show where Müge Çevik may publish in the future.

Co-authorship network of co-authors of Müge Çevik

This figure shows the co-authorship network connecting the top 25 collaborators of Müge Çevik. A scholar is included among the top collaborators of Müge Çevik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Müge Çevik. Müge Çevik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-pharmaceutical interventions for COVID-19: a systematic review on environmental control measures 2023 ·Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences ·(unknown), Christopher Iddon, Müge Çevik, James H. Naismith, Shaun Fitzgerald	8
2	Clinical course and management of COVID-19 in the era of widespread population immunity 2023 ·Nature Reviews Microbiology ·Eric A. Meyerowitz, Jake Scott, Aaron Richterman, Victoria Male, Müge Çevik	23
3	In-person schooling is essential even during periods of high transmission of COVID-19 2023 ·BMJ evidence-based medicine ·Alasdair Munro, Danilo Buonsenso, Sebastián González‐Dambrauskas, Robert C. Hughes, Sunil Bhopal, Pablo Vásquez‐Hoyos, Müge Çevik, (unknown), Damian Roland	7
4	Emergence of mpox in the post-smallpox era—a narrative review on mpox epidemiology 2023 ·Clinical Microbiology and Infection ·Christophe Van Dijck, Nicole A. Hoff, Placide Mbala‐Kingebeni, Nicola Low, Müge Çevik, Anne W. Rimoin, Jason Kindrachuk, Laurens Liesenborghs	26
5	Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis 2022 ·PLoS Medicine ·Diana Buitrago‐García, Aziz Mert Ipekci, (unknown), Hira Imeri, (unknown), Ingrid Arévalo-Rodríguez, Agustín Ciapponi, Müge Çevik, Anthony Hauser, (unknown), (unknown), Eric A. Meyerowitz, (unknown), Xueting Qiu, Aaron Richterman, (unknown), (unknown), I. Zhelyazkov, Georgia Salanti, Nicola Low	41
6	Competing health risks associated with the COVID-19 pandemic and early response: A scoping review 2022 ·PLoS ONE ·Stefan Baral, Amrita Rao, (unknown), Carrie Lyons, Müge Çevik, Anna Kågesten, Daouda Diouf, Annette H. Sohn, Nancy Phaswana‐Mafuya, Adeeba Kamarulzaman, Gregorio A. Millett, Julia L. Marcus, Sharmistha Mishra	18
7	Competing Health Risks Associated with the COVID-19 Pandemic and Early Response: A Scoping Review 2021 ·medRxiv ·Stefan Baral, Amrita Rao, (unknown), Carrie Lyons, Müge Çevik, Anna Kågesten, Daouda Diouf, Annette H. Sohn, Nancy Phaswana‐Mafuya, Adeeba Kamarulzaman, Gregorio A. Millett, Julia L. Marcus, Sharmistha Mishra	22
8	Gender disparities in coronavirus disease 2019 clinical trial leadership 2021 ·Clinical Microbiology and Infection ·Müge Çevik, Syed Arefinul Haque, Jennifer Manne‐Goehler, Krutika Kuppalli, Paul E. Sax, Maimuna S. Majumder, Chloe Orkin	24
9	COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants 2021 ·Cell ·Müge Çevik, Nathan D. Grubaugh, Akiko Iwasaki, Peter Openshaw	88
10	How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19 2021 ·European Journal of Epidemiology ·Emma K. Accorsi, Xueting Qiu, (unknown), Lee Kennedy‐Shaffer, Rebecca Kahn, Keya Joshi, Edward Goldstein, Mats Julius Stensrud, René Niehus, Müge Çevik, Marc Lipsitch	73
11	Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study 2020 ·Clinical Infectious Diseases ·Anna María Geretti, Alexander Stockdale, Sophie Kelly, Müge Çevik, Simon Collins, Laura Waters, Giovanni Carlo Federico Villa, Annemarie B Docherty, Ewen M. Harrison, Lance Turtle, Peter Openshaw, J. Kenneth Baillie, Caroline Sabin, Malcolm G. Semple	175
12	On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community 2020 ·The Journal of Infectious Diseases ·Edward Goldstein, Marc Lipsitch, Müge Çevik	187
13	Risk factors associated with poor clinical outcome in pyogenic spinal infections: 5-years’ intensive care experience 2020 ·The Journal of Infection in Developing Countries ·Branko Milošević, Müge Çevik, Aleksandar Urošević, Nataša Marković, (unknown), (unknown), Ivana Milošević, Jelena Micić, Bianca Paglietti, Aleksandra Barać	4
14	Submissions and publications in corona times 2020 ·Clinical Microbiology and Infection ·Leonard Leibovici, Franz Allerberger, Müge Çevik, Angela Huttner, Mical Paul, Jesús Rodríguez‐Baño, Luigia Scudeller	1
15	COVID-19 pandemic—a focused review for clinicians 2020 ·Clinical Microbiology and Infection ·Müge Çevik, Connor Bamford, Antonia Ho	253
16	Pneumocystis pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19 2020 ·Clinical Medicine ·Sophie Kelly, Laura Waters, Müge Çevik, Simon Collins, Joseph M. Lewis, (unknown), Tom Blanchard, Anna María Geretti	27
17	SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis breakdown → 2020 ·The Lancet Microbe ·Müge Çevik, Matthew Tate, Ollie Lloyd, Alberto Enrico Maraolo, Jenna Schafers, Antonia Ho	842
18	How scientists and physicians use Twitter during a medical congress 2019 ·Clinical Microbiology and Infection ·Müge Çevik, David S. Y. Ong, Graham Mackenzie	17
19	Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey 2008 ·Clinical Microbiology and Infection ·Müge Çevik, Ufuk Beyazova, (unknown), Aysu Duyan Çamurdan, Síbel A. Özkan, Figen Şahin, Cemalettin Aybay	16
20	Five-year surveillance of nosocomial infections in Ankara Training and Research Hospital 2006 ·Journal of Hospital Infection ·Fatma Şebnem Erdinç, Meltem Arzu Yetkin, Çigdem Ataman Hatipoğlu, (unknown), Ayhan Karakoç, Müge Çevik, Necla Tülek	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact